ADH-503
| CAS No. | 2055362-72-4 | Cat. No. | BCP44222 |
| Name | ADH-503 | ||
| Synonyms | ADH 503; ADH503;Leukadherin-1; | ||
| Formula | C22H15NO4S2 | M. Wt | 421.49 |
| Description | ADH-503 is a potent agonist of the integrin CD11b to mitigate myeloid cell immunosuppression. The partial activation of CD11b by ADH-503 leads to the repolarization of tumor-associated macrophages, reduction in the number of tumor-infiltrating immunosuppressive myeloid cells, and enhanced dendritic cell responses. These actions, in turn, improve antitumor T cell immunity and render checkpoint inhibitors effective in previously unresponsive PDAC models. | ||
| Related Products | 2055362-74-6（ADH503 choline） | ||
| Pathways | Others Pathway | ||
| Targets | Others | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.